BOTTI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 9.593
AS - Asia 1.815
EU - Europa 1.418
SA - Sud America 255
Continente sconosciuto - Info sul continente non disponibili 247
AF - Africa 26
OC - Oceania 2
Totale 13.356
Nazione #
US - Stati Uniti d'America 9.511
SG - Singapore 707
CN - Cina 459
IT - Italia 245
RU - Federazione Russa 234
BR - Brasile 199
HK - Hong Kong 191
DE - Germania 180
IE - Irlanda 178
VN - Vietnam 168
UA - Ucraina 125
FR - Francia 123
SE - Svezia 77
GB - Regno Unito 67
BD - Bangladesh 66
KR - Corea 62
FI - Finlandia 53
PL - Polonia 49
JP - Giappone 47
CA - Canada 43
IN - India 25
AR - Argentina 17
NL - Olanda 17
BE - Belgio 16
MX - Messico 13
EC - Ecuador 12
ES - Italia 11
CO - Colombia 10
TR - Turchia 10
AT - Austria 9
IQ - Iraq 9
MY - Malesia 9
ID - Indonesia 8
UZ - Uzbekistan 7
CR - Costa Rica 6
CL - Cile 5
CZ - Repubblica Ceca 5
KG - Kirghizistan 5
PH - Filippine 5
VE - Venezuela 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
EU - Europa 4
JO - Giordania 4
KE - Kenya 4
NG - Nigeria 4
PK - Pakistan 4
PY - Paraguay 4
EG - Egitto 3
IL - Israele 3
LT - Lituania 3
MA - Marocco 3
MD - Moldavia 3
NP - Nepal 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AZ - Azerbaigian 2
BS - Bahamas 2
CY - Cipro 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CU - Cuba 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SV - El Salvador 1
TN - Tunisia 1
Totale 13.113
Città #
Wilmington 1.814
Houston 1.791
Woodbridge 1.411
Fairfield 489
Ashburn 465
Singapore 427
Chandler 422
Ann Arbor 295
San Jose 251
Seattle 223
Beijing 207
Hong Kong 185
Cambridge 176
Dublin 163
Medford 124
Dearborn 119
New York 114
Council Bluffs 99
Jacksonville 85
Rome 84
Santa Clara 78
The Dalles 70
Los Angeles 69
Lawrence 57
Hanoi 46
Lauterbourg 46
Ho Chi Minh City 43
Tokyo 43
Dallas 39
Moscow 38
Kraków 35
Buffalo 33
Helsinki 33
São Paulo 32
Munich 31
San Diego 31
Denver 26
Atlanta 21
Turin 20
Redwood City 17
Boardman 16
Guangzhou 16
Chicago 15
Milan 15
Brussels 14
North Bergen 14
Shanghai 14
Nuremberg 12
Zhengzhou 12
Brooklyn 11
Da Nang 11
Montreal 11
Nanjing 11
Toronto 11
Kunming 10
Orem 10
Warsaw 10
London 9
Manchester 9
Redondo Beach 9
Stockholm 9
Chennai 8
Mülheim 8
Columbus 7
Hefei 7
Jinan 7
Menlo Park 7
Norwalk 7
Phoenix 7
Poplar 7
San Francisco 7
Wuhan 7
Frankfurt am Main 6
Mountain View 6
Paris 6
Quito 6
Salt Lake City 6
San Mateo 6
Amsterdam 5
Bogotá 5
Boston 5
Curitiba 5
Falls Church 5
Hounslow 5
Miami 5
Newark 5
Nha Trang 5
Pune 5
Saint Louis 5
Utrecht 5
Vancouver 5
Amman 4
Ankara 4
Biên Hòa 4
Bắc Giang 4
Cagliari 4
Cangzhou 4
Casarile 4
Centrale 4
Chengdu 4
Totale 10.217
Nome #
Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo 583
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 540
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 525
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 504
IL-21 in the pathogenesis and treatment of skin diseases 459
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 458
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 452
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 421
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 420
Clindamycin versus clindamycin plus rifampicin in Hidradenitis Suppurativa treatment: clinical and ultrasound observations 403
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 390
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 385
IL-21, a new player in pathogenesis of psoriasis 367
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 358
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 352
Potential Role of Cytochrome c and Tryptase in Psoriasis and Psoriatic Arthritis Pathogenesis: Focus on Resistance to Apoptosis and Oxidative Stress 318
Long-term efficacy and safety of adalimumab on a severe case of Hidradenitis Suppurativa 302
Bowel-associated dermatosis arthritis syndrome and palisading neutrophilic granulomatous dermatitis as presentation of ulcerative colitis 276
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 233
Cutaneous mastocytosis: a dermatological perspective 222
p53 promuove la progressione tumorale nelle cellule di melamona resistenti agli inibitori di BRAF 203
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: a case series and literature review 203
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 197
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 195
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 192
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 175
Vulvar basal cell carcinoma, so rare? 172
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 169
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 165
Dimethylfumarate efficacy and safety in palmoplantar psoriasis patient affected by hepatitis b and depression: A case report 164
Allele-specific cytokine responses at the HLA-C locus: Implications for psoriasis 157
Genetic markers predictive of clinical response to biological drugs in psoriasis. 155
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 155
Nanomedicine in dermatology: Benefits and emerging applications 154
Confocal, wide band spectral reflection microscope, and relevant spectral imaging method 151
Investigating the expression of the susceptibility allele HLA-Cw6 in psoriasis using a specific single chain fragment antibody 150
Suicide risk and psychiatric comorbidity in patients with psoriasis. 147
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 145
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 144
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis 142
Patients with moderate to severe plaque psoriasis: One year after the European medicines agency recommendation of efalizumab suspension 142
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 138
Targeted therapy in nonmelanoma skin cancers 136
Assessing the expression of HLA-Cw6 using specific single chain antibody (scFv) 125
A Longitudinal Multiinstitutional Study of Vulvar Lichen Sclerosus: From Childhood to Perimenopause 121
TRIM8 and p53: Making the right decision 115
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 112
Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy 111
Programmed cell death in the skin 109
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 108
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 104
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 93
HLA-C*06:02 allele can influence clinical efficacy of certolizumab pegol? 93
Use of brodalumab for the treatment of chronic plaque psoriasis: a one-year real-life study in the Lazio region, Italy 88
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy 83
Genetic variations in IL6 and IL12B as protective markers for psoriasis 83
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom 76
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients 74
Usefulness of topical imiquimod 3.75% in cytokeratin 7 positive extramammary paget disease of the vulva: towards personalized therapy 73
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients 69
Totale 13.356
Categoria #
all - tutte 41.166
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.166


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022468 0 0 0 23 18 36 45 23 38 53 55 177
2022/2023845 91 81 73 108 56 210 57 43 82 5 31 8
2023/2024314 34 7 19 7 32 95 12 29 4 8 9 58
2024/20251.170 66 240 122 95 13 71 114 54 82 100 76 137
2025/20262.179 176 101 251 222 215 82 326 213 225 197 105 66
2026/2027886 110 119 419 238 0 0 0 0 0 0 0 0
Totale 13.356